Alur Orthopedic Implants
Alur Orthopedic Implants
Doha has rapidly transformed into a global hub for medical innovation, driven by the Qatar National Vision 2030. As a premier manufacturer and exporter of Total Hip Replacement (THR) solutions, we have aligned our production capabilities with the sophisticated needs of the Middle Eastern healthcare sector. The demand for orthopedic implants in Doha is fueled by a combination of a growing aging population, a high prevalence of metabolic bone diseases, and the presence of world-class facilities like Hamad Medical Corporation (HMC) and Sidra Medicine.
Our role in Doha goes beyond simple manufacturing; we are an integral part of the supply chain that supports surgical excellence. With the strategic advantage of Hamad International Airport and Hamad Port, our export operations from Doha reach across the GCC, Africa, and South America with unparalleled efficiency. The local industrial context is characterized by a shift toward localized medical device production, reducing reliance on long-distance imports and ensuring that Qatar-based surgeons have immediate access to life-changing orthopedic technologies.
In Doha's thriving medical economy, we focus on producing biocompatible implants that can withstand the unique physiological profiles of the local demographic. From cementless titanium alloys to advanced ceramic-on-polyethylene bearings, our THR systems are engineered to provide maximum longevity and stability, catering to both high-activity younger patients and elderly patients with osteoarthritis.
Year Founded
Exp. Countries
Top-tier Hospitals
IP Certificates
Global Agents
Our product development focuses on differentiation. By targeting limb orthopedics and pediatric orthopedic needs, we solve complex surgical challenges that traditional manufacturers overlook.
Utilizing 3D modeling and AI-assisted design, we ensure that every THR femoral head and acetabular cup meets sub-micron tolerance levels for perfect osseointegration.
With 27 utility model patents and 6 invention patents, our R&D team in Doha and abroad is constantly pushing the boundaries of surgical instrument efficiency.
The company places great importance on scientific and technological innovation, as well as new product research and development. Its product development strategy follows the principles of "blue ocean, differentiation, and focus strategy," with a strong emphasis on limb orthopedics, pediatric orthopedics, and internal and external fixation products for foot and ankle surgery. We have obtained 27 national utility model patent certificates, 6 invention patents, and 2 software copyrights.
With a production capacity covering more than 8,000 product specifications in orthopedic trauma, spinal implants, and surgical instruments, the company has gradually established competitive advantages in research and development, production and manufacturing, quality control, marketing, and other key areas.
One of the most prominent application scenarios for our Total Hip Replacement systems in Doha is the Aspetar Sports Medicine Hospital. Doha is known as a world leader in sports science, and high-performance athletes often require advanced joint interventions. Our Ti-Alloy cementless systems are designed for the high-impact demands of athletes returning to activity, providing a biological bond between the bone and the implant that is far superior to traditional cemented methods.
Furthermore, in the public sector, the Hamad Medical Corporation relies on robust surgical tools. Our low-speed drills and oscillating saws, manufactured with medical-grade precision, are staples in Doha's operating theaters. We have specifically optimized our power tools for the high-turnover environment of Qatar's trauma centers, ensuring that batteries (such as our high-performance replacements) and chargers are always ready for the next emergency procedure.
We also address specific regional needs, such as hip dysplasia secondary to osteoarthritis, which is increasingly diagnosed in the Gulf region. Our specialized instrument sets for THR and TKR (Total Knee Replacement) allow surgeons to perform complex revisions and primary surgeries with 100% confidence, backed by our technical service personnel present in major cities.
Our marketing team consists of more than 40 professionals, with sales and technical service personnel present in over 20 major cities. In Doha, we act as a bridge between high-tech manufacturing and clinical application. The company has built a nationwide marketing network covering 31 provinces and cities, collaborating with more than 300 agents and serving over 300 top-tier teaching hospitals.
We don't just sell products; we foster an academic ecosystem. By participating in or hosting more than 50 academic conferences for orthopedic doctors annually, we ensure that surgeons in Doha are at the forefront of arthroplasty techniques. Our self-operated export business is also taking shape, with sales extending to countries such as Brazil, Colombia, Peru, Egypt, and Morocco, all managed through our strategic hub in Doha.
The synergy between our production capacity and our commitment to academic promotion makes us the preferred partner for healthcare providers in Qatar and the wider MENA region. Whether it is a primary hip replacement or a complex femoral condyle revision, our portfolio is designed to deliver excellence.
As we look toward the next decade, the integration of Artificial Intelligence (AI) in surgical planning and implant manufacturing is becoming a reality in Doha. Our R&D department is currently exploring smart implants that can transmit data regarding wear and tear directly to surgeons, a concept that aligns perfectly with Doha's ambition to be a leading "Smart City" in the Middle East.
Environmental sustainability is also a key factor in our Doha industrial strategy. We are optimizing our manufacturing processes to reduce waste in Ti-Alloy production and implementing sterile packaging solutions that minimize environmental impact, meeting the green building and sustainability codes often required by the Qatar Ministry of Public Health (MoPH).
Our commitment to Doha is steadfast. By providing not only the implants but the surgical power tools—like the Ss-1011 Orthopedic Thr Total Hip Replacement Oscillating Surgical Saw—we offer a turnkey solution for hospitals. This holistic approach ensures that surgeons have consistent, high-quality tools that they can trust in every procedure.
Finally, our export hub in Doha serves as a critical link for South-South cooperation. By exporting high-quality, cost-effective orthopedic solutions to emerging markets in South America and Africa, we are helping to democratize access to life-changing surgery, all while maintaining the high standards associated with Doha's medical industry.
